Template:Dgfn2015 Mo 7:00 PCSK9

From HOP house of papers
Revision as of 13:15, 14 September 2015 by Ossip Groth (Talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Journal article, free access
GET A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease Extract PDF direct
Journal article, free access
GET Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates Extract PDF direct
Journal article, free access
GET The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia Extract PDF direct
Journal article, free access
GET Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Extract PDF direct
Journal article, free access
GET A century of cholesterol and coronaries: from plaques to genes to statins Extract PDF direct
Journal article, free access
GET Targeting PCSK9 for hypercholesterolemia Extract PDF direct
Journal article, free access
GET The biology and therapeutic targeting of the proprotein convertases Extract PDF direct
Journal article, free access
GET Plasma membrane CD81 complexes with PCSK9 and LDLR and its levels are reduced by PCSK9 Extract PDF direct
Journal article, free access
GET Protease variants, LDL, and coronary heart disease Extract PDF direct
Personal tools
Namespaces
Variants
Actions
Navigation
Toolbox
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis